- Fee assured
- Awaiting verification
This healthcare professional let us know that they are currently available for:
- Phone consultations
Last updated: 12 Nov 2020
- Metabolic medicine
Dr Song qualified from Edinburgh University and undertook postgraduate clinical and research training in Edinburgh, Yorkshire and Los Angeles. Since 2004, he has been a consultant physician and diabetologist in Northern General Hospital, Sheffield.
His clinical practice includes managing acute and chronic general medical conditions, heart failure, hypertension, cholesterol problems, general diabetes conditions and specialist diabetes areas including antenatal diabetes, insulin pumps, diabetic renal disease, young type 2 diabetes and cardiovascular risk.
He is the clinical lead for antenatal diabetes, insulin pump, young type 2 diabetes, diabetic renal disease and heart failure services. He is also involved in the formulation of guidelines for lipid and hypertension management in Sheffield.
Nationally, he is actively involved in the postgraduate MRCP (UK) examination and is a member of the Specialty Question Group for Diabetes & Endocrinology, Question Writing Group for MRCP (UK) PACES scenario, Specialty Certificate Examination Board for Diabetes & Endocrinology and MRCP Part 1 Examination Board.
His research interest focused specifically on cardiovascular risk and complications in young type 2 diabetes.
Areas of interest
General medical conditions
Cholesterol or lipid problems
Cardiovascular risk assessment
Current NHS consultant posts held
Department of Diabetes and Endocrinology
Northern General Hospital
Sheffield S5 7AU
Cardiovascular risk and complications in young people with type 2 diabetes
Golf, racquet sports, music
Distinction in Biochemistry – Edinburgh University 1988
Wightman Prize in Clinical Medicine – Edinburgh University 1992
Doctor of Medicine awarded with distinction – Edinburgh University 2000
Endocrine Society International Award for Excellence in Published Clinical Research in JCEM (First prize) – American Endocrine Society for best JCEM paper 2001
Heart UK Best poster prize 2010
Sheffield Teaching Hospitals Thank You Award 2012
(Additional) Languages spoken
Song SH. Complication characteristics between young-onset young type 2 vs type 1 diabetes in a UK population. BMJ Open Diabetes Res Care 2015;3:e000044. doi: 10.1136/bmjdrc-2014-000044
Song SH. Young-onset type 2 diabetes: no room for complacency. Lancet Diabetes Endocrinol 2014;2:924-5
Song SH, Gray TA. Early-onset type 2 diabetes: higher burden of atherogenic apolipoprotein particles during statin treatment. QJM 2012;105:973-980
Song SH. Emerging type 2 diabetes in young adults. Adv Exp Med Biol. 2012;771:51-61
Song SH, Gray TA. Early-onset type 2 diabetes: high risk for premature diabetic retinopathy. Diabetes Res Clin Pract 2011;94:207-211
Benhalima K, Song SH, Wilmot EG, Khunti K, Gray LJ, Lawrence I, Davies M. Characteristics, complications and management of a large multiethnic cohort of younger adults with type 2 diabetes. Prim Care Diabetes 2011;5:245-250
Song SH, Gray TA. Early intensive cardiovascular risk management in young people with type 2 diabetes. Diabetes Res Clin Pract 2011; 92(3):e70-72
Gunathilake W, Song S, Sridharan S, Fernando DJ, Idris I. Cardiovascular and metabolic risk profiles in young and old patients with type 2 diabetes. QJM 2010;103:881-884
Song SH, Gray TA, Tesfaye S. Time to rethink aspirin in diabetes? BMJ 2009;339:b5588
Song SH, Hardisty CA. Early onset type 2 diabetes mellitus: a harbinger for complications in later years – clinical observation from a secondary care cohort. QJM 2009:102;799-806
Song SH, Hardisty CA. Type 2 diabetes mellitus: a high-risk condition for cardiovascular disease irrespective of the different degrees of obesity. QJM 2008;101:875-879
Song SH. Early-onset type 2 diabetes mellitus: a condition with elevated cardiovascular risk? Br J Diabetes Vasc Dis 2008;8:61-65
Song SH, Hardisty CA. Diagnosing metabolic syndrome in type 2 diabetes: does it matter? QJM 2008;101:487-491
Song SH, Hardisty CA. Early-onset type 2 diabetes mellitus: an increasing phenomenon of elevated cardiovascular risk. Expert Rev Cardiovasc Ther 2008;6:315-322
Siyambalapitiya S, Bulugahapitiya U, Sithole J, Song SH, Fernando DJS, Idris I. Combining population health and baseline risk strategy by determining an appropriate age cut-off for initiating statins to reduce cardiovascular disease in patients with type 2 diabetes: a population-based study. Diabetes Care 2007;30:2025-2029
- MBChB Edinburgh University 1992
- MD (with distinction) Edinburgh University 2000
- FRCP Royal College of Phusicians Edinburgh 2006
- FRCP Royal College of Physicians London 2008
Reference number 3668654
Details of entry to specialist register
- General Medical Council, 1993
Affiliations / memberships
- BMI Thornbury Hospital 312 Fulwood Road...
- 18:30 - 21:00
- 0114 267 4536
- Claremont Hospital 401 Sandygate Road...
- 18:00 - 21:00
- 0114 263 0330
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.